🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-527465-30-00
Authorised Phase I

A study to evaluate how well linaprazan glurate is absorbed and how it controls stomach acid (Part I) and investigation of the influence of a meal on the blood levels of linaprazan glurate (Part II) in healthy volunteers

2026-527465-30-00 · tracked via the Priya Life Science EU tracker
Sponsor
Cinclus Pharma Holding AB (publ)
Sponsor type
Pharmaceutical company
Therapeutic area
Bacterial Infections and Mycoses
Decision date
14/09/2026
Enrollment target
64
Sites
Germany

Condition studied

Healthy volunteer

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-527465-30-00 on CTIS ↗ ← All trials in the EU